SCHEMBL9545528

SCHEMBL9545528

c1ccc([C@@H]2CCC[C@@H](c3ccccn3)C23c2ccccc2-c2nccnc23)nc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.38
PDK2 Q15119 3/20 0.37
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
ALDH1A1 P00352 3/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9545525 0.86 PDK2 (0.32) PDK2KMT2ACYP1A2CYP2C19
SCHEMBL9198100 0.71 NFKB1 (0.46) PDK2KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL9198107 0.71 NFKB1 (0.46) PDK2KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL9545522 0.68
SCHEMBL9545130 0.67 CYP19A1 (0.37) PDK2KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL9545138 0.67 CYP19A1 (0.37) PDK2KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL19009214 0.65 PDK2 (0.42) PDK2KMT2ACYP1A2CYP2C19ALDH1A1
SCHEMBL5951384 0.64 ALDH1A1 (0.43) GSK3BKMT2ACYP1A2ALDH1A1MAPT
SCHEMBL9194471 0.64 GSK3B (0.47) GSK3BPDK2KMT2ACYP1A2CYP2C19
SCHEMBL30658986 0.64 PDK2 (0.44) PDK2KMT2ACYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993021185-A1 SUBSTITUTED NITROGEN CONTAINING SPIRO COMPOUNDS FOR USE IN TREATING COGNITIVE DEFICITS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-10-28 WO disclosed